Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 105 | 2024 | 1336 | 18.020 |
Why?
|
Sarcomeres | 43 | 2024 | 379 | 9.150 |
Why?
|
Genetic Testing | 31 | 2024 | 3591 | 2.830 |
Why?
|
Hypertrophy, Left Ventricular | 24 | 2024 | 856 | 2.820 |
Why?
|
Benzylamines | 6 | 2021 | 251 | 1.960 |
Why?
|
Uracil | 6 | 2021 | 210 | 1.790 |
Why?
|
Cardiac Myosins | 14 | 2023 | 128 | 1.580 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 7 | 2024 | 428 | 1.530 |
Why?
|
Mutation | 44 | 2024 | 30213 | 1.330 |
Why?
|
Myosin Heavy Chains | 13 | 2021 | 403 | 1.130 |
Why?
|
Cardiomyopathy, Dilated | 7 | 2017 | 843 | 1.120 |
Why?
|
Ventricular Function, Left | 16 | 2023 | 3935 | 1.120 |
Why?
|
Magnetic Resonance Imaging, Cine | 12 | 2022 | 1089 | 1.070 |
Why?
|
Ventricular Dysfunction, Left | 10 | 2023 | 2143 | 1.020 |
Why?
|
Defibrillators, Implantable | 7 | 2021 | 1499 | 1.020 |
Why?
|
Exercise Tolerance | 6 | 2024 | 847 | 0.990 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 5 | 2012 | 63 | 0.960 |
Why?
|
Heart Failure | 18 | 2023 | 11882 | 0.920 |
Why?
|
Genetic Counseling | 6 | 2024 | 634 | 0.910 |
Why?
|
Phenotype | 33 | 2024 | 16724 | 0.880 |
Why?
|
Myocardium | 13 | 2023 | 4765 | 0.870 |
Why?
|
Death, Sudden, Cardiac | 15 | 2022 | 1567 | 0.850 |
Why?
|
Ventricular Remodeling | 10 | 2024 | 1281 | 0.840 |
Why?
|
Myocardial Contraction | 7 | 2020 | 1516 | 0.820 |
Why?
|
Genetic Predisposition to Disease | 32 | 2024 | 18075 | 0.810 |
Why?
|
Troponin T | 9 | 2023 | 786 | 0.800 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 78 | 0.790 |
Why?
|
Pedigree | 15 | 2023 | 4539 | 0.790 |
Why?
|
Carrier Proteins | 18 | 2022 | 4924 | 0.780 |
Why?
|
Echocardiography | 21 | 2021 | 5037 | 0.780 |
Why?
|
Cardiomyopathies | 10 | 2023 | 2059 | 0.770 |
Why?
|
Heart Ventricles | 11 | 2021 | 3832 | 0.680 |
Why?
|
Heterozygote | 6 | 2021 | 2795 | 0.640 |
Why?
|
Exercise Test | 3 | 2024 | 2188 | 0.630 |
Why?
|
Registries | 16 | 2024 | 8351 | 0.610 |
Why?
|
Heart | 6 | 2024 | 4425 | 0.600 |
Why?
|
Atrial Fibrillation | 8 | 2024 | 5182 | 0.600 |
Why?
|
Echocardiography, Doppler | 8 | 2016 | 899 | 0.590 |
Why?
|
Losartan | 4 | 2023 | 263 | 0.510 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 849 | 0.470 |
Why?
|
Humans | 143 | 2024 | 766766 | 0.470 |
Why?
|
Founder Effect | 2 | 2020 | 185 | 0.470 |
Why?
|
Genotype | 17 | 2020 | 13036 | 0.470 |
Why?
|
Genetic Variation | 11 | 2024 | 6612 | 0.460 |
Why?
|
Calcium Channel Blockers | 3 | 2020 | 687 | 0.460 |
Why?
|
Diltiazem | 1 | 2014 | 132 | 0.460 |
Why?
|
Cardiology | 4 | 2024 | 1701 | 0.450 |
Why?
|
Double-Blind Method | 12 | 2024 | 12430 | 0.450 |
Why?
|
Diastole | 8 | 2018 | 784 | 0.450 |
Why?
|
Adult | 66 | 2024 | 223307 | 0.430 |
Why?
|
Genetics, Medical | 3 | 2018 | 334 | 0.410 |
Why?
|
Fibrosis | 8 | 2022 | 2077 | 0.400 |
Why?
|
Young Adult | 31 | 2024 | 59939 | 0.400 |
Why?
|
American Heart Association | 3 | 2024 | 1049 | 0.390 |
Why?
|
Heart-Assist Devices | 3 | 2021 | 1287 | 0.390 |
Why?
|
Male | 84 | 2024 | 364142 | 0.380 |
Why?
|
Contrast Media | 4 | 2022 | 5329 | 0.380 |
Why?
|
Mitral Valve | 3 | 2018 | 1473 | 0.370 |
Why?
|
Adolescent | 35 | 2024 | 88904 | 0.360 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1029 | 0.360 |
Why?
|
Female | 84 | 2024 | 396520 | 0.350 |
Why?
|
Disease Progression | 13 | 2024 | 13640 | 0.350 |
Why?
|
Middle Aged | 63 | 2024 | 223257 | 0.340 |
Why?
|
Procollagen | 1 | 2010 | 189 | 0.340 |
Why?
|
Child | 25 | 2024 | 80668 | 0.330 |
Why?
|
Muscle Proteins | 5 | 2021 | 1160 | 0.330 |
Why?
|
Troponin I | 3 | 2024 | 659 | 0.320 |
Why?
|
Cost of Illness | 1 | 2018 | 1949 | 0.310 |
Why?
|
Glycogen Storage Disease Type IIb | 2 | 2023 | 18 | 0.310 |
Why?
|
Heart Diseases | 2 | 2013 | 2817 | 0.280 |
Why?
|
Electrocardiography | 7 | 2018 | 6408 | 0.270 |
Why?
|
Penetrance | 3 | 2023 | 388 | 0.270 |
Why?
|
Mutation, Missense | 6 | 2021 | 2590 | 0.270 |
Why?
|
Lamin Type A | 2 | 2017 | 186 | 0.260 |
Why?
|
Predictive Value of Tests | 13 | 2022 | 15416 | 0.250 |
Why?
|
Genetics | 2 | 2024 | 114 | 0.250 |
Why?
|
Risk Factors | 16 | 2023 | 74881 | 0.250 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2006 | 310 | 0.250 |
Why?
|
Extracellular Matrix | 1 | 2013 | 1730 | 0.240 |
Why?
|
Peptide Fragments | 2 | 2024 | 5143 | 0.240 |
Why?
|
Patient Care | 1 | 2010 | 629 | 0.240 |
Why?
|
DNA Mutational Analysis | 6 | 2017 | 4114 | 0.240 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2006 | 153 | 0.240 |
Why?
|
Primary Prevention | 2 | 2021 | 1188 | 0.220 |
Why?
|
Quality of Life | 3 | 2024 | 13476 | 0.220 |
Why?
|
Arrhythmias, Cardiac | 4 | 2023 | 2258 | 0.220 |
Why?
|
Prognosis | 12 | 2023 | 29948 | 0.220 |
Why?
|
Aged | 40 | 2024 | 171343 | 0.220 |
Why?
|
Disease | 1 | 2009 | 675 | 0.220 |
Why?
|
Heart Septum | 2 | 2024 | 303 | 0.210 |
Why?
|
Child, Preschool | 13 | 2022 | 42577 | 0.210 |
Why?
|
Sex Characteristics | 4 | 2022 | 2645 | 0.200 |
Why?
|
Cardiovascular Diseases | 5 | 2020 | 15657 | 0.200 |
Why?
|
Hypertrophy | 2 | 2022 | 562 | 0.200 |
Why?
|
Stroke Volume | 6 | 2023 | 5618 | 0.190 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2022 | 61 | 0.190 |
Why?
|
Databases, Genetic | 2 | 2021 | 1756 | 0.190 |
Why?
|
Risk Assessment | 10 | 2022 | 24295 | 0.190 |
Why?
|
Tropomyosin | 3 | 2013 | 105 | 0.190 |
Why?
|
Heart Arrest | 2 | 2023 | 1516 | 0.190 |
Why?
|
Asymptomatic Diseases | 3 | 2020 | 588 | 0.190 |
Why?
|
Point Mutation | 2 | 2010 | 1591 | 0.180 |
Why?
|
Family | 4 | 2024 | 3209 | 0.180 |
Why?
|
Genomics | 4 | 2024 | 5923 | 0.180 |
Why?
|
Recovery of Function | 3 | 2020 | 2976 | 0.180 |
Why?
|
Genome, Human | 3 | 2021 | 4443 | 0.180 |
Why?
|
Genes, Dominant | 3 | 2013 | 855 | 0.170 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2020 | 262 | 0.170 |
Why?
|
Denmark | 2 | 2019 | 777 | 0.170 |
Why?
|
Early Diagnosis | 2 | 2018 | 1186 | 0.170 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 4 | 2023 | 53 | 0.160 |
Why?
|
Twins, Monozygotic | 1 | 2021 | 471 | 0.160 |
Why?
|
Genetic Markers | 4 | 2015 | 2603 | 0.160 |
Why?
|
Systole | 3 | 2018 | 935 | 0.160 |
Why?
|
Cardiac Imaging Techniques | 2 | 2018 | 280 | 0.160 |
Why?
|
Muscle Relaxation | 2 | 2020 | 138 | 0.160 |
Why?
|
Online Systems | 1 | 2019 | 181 | 0.150 |
Why?
|
Mortality | 2 | 2020 | 2910 | 0.150 |
Why?
|
Heart Atria | 3 | 2021 | 1361 | 0.150 |
Why?
|
Age Factors | 5 | 2020 | 18397 | 0.150 |
Why?
|
Mass Screening | 4 | 2019 | 5454 | 0.150 |
Why?
|
Papillary Muscles | 1 | 2018 | 192 | 0.150 |
Why?
|
Myofibrils | 2 | 2020 | 143 | 0.140 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.140 |
Why?
|
Hospitals, Special | 1 | 2017 | 89 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 36567 | 0.140 |
Why?
|
Myocytes, Cardiac | 3 | 2020 | 1673 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2024 | 839 | 0.130 |
Why?
|
Atrial Function, Left | 1 | 2017 | 188 | 0.130 |
Why?
|
Time Factors | 8 | 2024 | 40149 | 0.130 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2014 | 252 | 0.130 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 878 | 0.130 |
Why?
|
Patient Selection | 2 | 2018 | 4252 | 0.130 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1996 | 228 | 0.130 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2024 | 1750 | 0.130 |
Why?
|
Blood Platelet Disorders | 1 | 1996 | 60 | 0.130 |
Why?
|
Homozygote | 1 | 2000 | 1775 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2022 | 325 | 0.130 |
Why?
|
Brazil | 1 | 2019 | 1249 | 0.120 |
Why?
|
Treatment Outcome | 8 | 2024 | 65273 | 0.120 |
Why?
|
Cardiac Volume | 1 | 2015 | 196 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1733 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2022 | 81635 | 0.120 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 26310 | 0.120 |
Why?
|
Canada | 1 | 2019 | 2126 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.110 |
Why?
|
Arterio-Arterial Fistula | 1 | 2013 | 20 | 0.110 |
Why?
|
Communication | 2 | 2018 | 3905 | 0.110 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 1996 | 249 | 0.110 |
Why?
|
Professional-Family Relations | 1 | 2017 | 500 | 0.110 |
Why?
|
Collagen | 2 | 2013 | 2635 | 0.110 |
Why?
|
Polymorphism, Genetic | 2 | 2020 | 4249 | 0.110 |
Why?
|
Cohort Studies | 8 | 2023 | 41710 | 0.110 |
Why?
|
Leukemia, Myeloid | 1 | 1996 | 695 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1168 | 0.100 |
Why?
|
Health Education | 1 | 2019 | 1060 | 0.100 |
Why?
|
Alleles | 2 | 2017 | 6895 | 0.100 |
Why?
|
Lod Score | 2 | 2006 | 600 | 0.090 |
Why?
|
Sequence Analysis, DNA | 3 | 2014 | 4780 | 0.090 |
Why?
|
Catheter Ablation | 2 | 2021 | 2786 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2024 | 39309 | 0.090 |
Why?
|
Hemodynamics | 3 | 2020 | 4188 | 0.090 |
Why?
|
Proteomics | 1 | 2024 | 3914 | 0.090 |
Why?
|
Heart Function Tests | 2 | 2014 | 316 | 0.090 |
Why?
|
Incidence | 5 | 2022 | 21525 | 0.090 |
Why?
|
Patient Participation | 1 | 2019 | 1445 | 0.090 |
Why?
|
Pilot Projects | 4 | 2019 | 8728 | 0.090 |
Why?
|
United States | 11 | 2024 | 72951 | 0.080 |
Why?
|
Case-Control Studies | 6 | 2021 | 22248 | 0.080 |
Why?
|
alpha-Galactosidase | 1 | 2010 | 58 | 0.080 |
Why?
|
Gadolinium DTPA | 1 | 2013 | 823 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2022 | 3581 | 0.080 |
Why?
|
Ventricular Myosins | 1 | 2009 | 65 | 0.080 |
Why?
|
Muscle Cells | 1 | 2010 | 194 | 0.080 |
Why?
|
Amino Acid Substitution | 2 | 2006 | 1742 | 0.080 |
Why?
|
Fabry Disease | 1 | 2010 | 89 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1142 | 0.080 |
Why?
|
Logistic Models | 3 | 2014 | 13278 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12825 | 0.080 |
Why?
|
Therapeutics | 1 | 2009 | 113 | 0.080 |
Why?
|
Animals | 9 | 2022 | 168930 | 0.080 |
Why?
|
Policy Making | 1 | 2012 | 547 | 0.080 |
Why?
|
Family Health | 1 | 2013 | 1254 | 0.080 |
Why?
|
Myosins | 1 | 2010 | 407 | 0.080 |
Why?
|
Medical History Taking | 1 | 2012 | 779 | 0.070 |
Why?
|
Health Status | 1 | 2021 | 4087 | 0.070 |
Why?
|
Primary Health Care | 2 | 2015 | 4735 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2020 | 1241 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3716 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3824 | 0.070 |
Why?
|
Disease Management | 3 | 2024 | 2533 | 0.070 |
Why?
|
Actins | 1 | 2014 | 2060 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2519 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10384 | 0.070 |
Why?
|
Collagen Type I | 1 | 2010 | 616 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3792 | 0.070 |
Why?
|
Blood Volume | 1 | 2008 | 544 | 0.070 |
Why?
|
Research | 1 | 2015 | 1977 | 0.070 |
Why?
|
Troponin | 1 | 2010 | 536 | 0.070 |
Why?
|
Models, Molecular | 1 | 2016 | 5386 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12534 | 0.060 |
Why?
|
Infant | 5 | 2022 | 36461 | 0.060 |
Why?
|
Societies, Medical | 1 | 2018 | 3957 | 0.060 |
Why?
|
Haplotypes | 2 | 2006 | 2727 | 0.060 |
Why?
|
Models, Statistical | 1 | 2020 | 5091 | 0.060 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 184 | 0.060 |
Why?
|
Contractile Proteins | 1 | 2006 | 240 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2022 | 18330 | 0.060 |
Why?
|
Protein Kinases | 1 | 2012 | 1610 | 0.060 |
Why?
|
Codon | 1 | 2006 | 599 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6214 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8926 | 0.060 |
Why?
|
Prevalence | 2 | 2018 | 15835 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3411 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7431 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2015 | 2744 | 0.060 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2024 | 198 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2006 | 663 | 0.050 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 594 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8066 | 0.050 |
Why?
|
Computational Biology | 1 | 2015 | 3564 | 0.050 |
Why?
|
Genetic Heterogeneity | 1 | 2006 | 735 | 0.050 |
Why?
|
Motion | 1 | 2006 | 783 | 0.050 |
Why?
|
Aneurysm, False | 1 | 2005 | 264 | 0.050 |
Why?
|
Energy Metabolism | 2 | 2020 | 2903 | 0.050 |
Why?
|
Coronary Circulation | 1 | 2008 | 1602 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6968 | 0.050 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2005 | 477 | 0.050 |
Why?
|
Long QT Syndrome | 1 | 2006 | 473 | 0.050 |
Why?
|
Heart Transplantation | 4 | 2020 | 3306 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3359 | 0.050 |
Why?
|
Ion Channels | 1 | 2006 | 1043 | 0.050 |
Why?
|
Prospective Studies | 7 | 2023 | 54871 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16044 | 0.050 |
Why?
|
Mice | 4 | 2022 | 81889 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4207 | 0.040 |
Why?
|
Calcium | 2 | 2013 | 5783 | 0.040 |
Why?
|
Iceland | 1 | 2020 | 183 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 149 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3459 | 0.040 |
Why?
|
DNA | 2 | 2010 | 7208 | 0.040 |
Why?
|
Age of Onset | 2 | 2020 | 3342 | 0.040 |
Why?
|
Algorithms | 4 | 2020 | 14072 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4344 | 0.040 |
Why?
|
Research Design | 1 | 2014 | 6207 | 0.040 |
Why?
|
Base Sequence | 1 | 2009 | 12415 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4619 | 0.040 |
Why?
|
Gadolinium | 1 | 2022 | 964 | 0.040 |
Why?
|
Endocardium | 1 | 2018 | 249 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 13090 | 0.040 |
Why?
|
Victoria | 1 | 2016 | 64 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 787 | 0.030 |
Why?
|
Capillaries | 1 | 2020 | 755 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 423 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14652 | 0.030 |
Why?
|
Virulence | 1 | 2020 | 1294 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 1065 | 0.030 |
Why?
|
Electric Countershock | 1 | 2020 | 534 | 0.030 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 224 | 0.030 |
Why?
|
Health Communication | 1 | 2019 | 216 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1638 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 315 | 0.030 |
Why?
|
Curriculum | 2 | 2024 | 3783 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20144 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2020 | 840 | 0.030 |
Why?
|
France | 1 | 2016 | 495 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3531 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1006 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15908 | 0.030 |
Why?
|
Singapore | 1 | 2015 | 299 | 0.030 |
Why?
|
London | 1 | 2014 | 233 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1874 | 0.030 |
Why?
|
Pericardium | 1 | 2018 | 681 | 0.030 |
Why?
|
Tachycardia, Ventricular | 1 | 2002 | 1313 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2013 | 6558 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3208 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3432 | 0.030 |
Why?
|
Cardiomegaly | 1 | 2016 | 591 | 0.030 |
Why?
|
Incidental Findings | 1 | 2018 | 698 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 2005 | 11513 | 0.030 |
Why?
|
Isometric Contraction | 1 | 2013 | 149 | 0.030 |
Why?
|
Italy | 1 | 2014 | 856 | 0.030 |
Why?
|
Phobic Disorders | 1 | 2015 | 440 | 0.030 |
Why?
|
Anti-Anxiety Agents | 1 | 2015 | 404 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12806 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59550 | 0.020 |
Why?
|
Protein Conformation | 1 | 2020 | 3947 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2014 | 538 | 0.020 |
Why?
|
Panic Disorder | 1 | 2015 | 613 | 0.020 |
Why?
|
Netherlands | 1 | 2016 | 2277 | 0.020 |
Why?
|
Inservice Training | 1 | 2014 | 374 | 0.020 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 606 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3053 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2013 | 482 | 0.020 |
Why?
|
Oncogenes | 1 | 1996 | 1231 | 0.020 |
Why?
|
Blood Pressure | 2 | 2021 | 8533 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1754 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 1996 | 1791 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1667 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 830 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2023 | 12985 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1882 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 682 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 2001 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2012 | 1494 | 0.020 |
Why?
|
Stroke | 2 | 2020 | 9741 | 0.020 |
Why?
|
Health Promotion | 1 | 2019 | 2209 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1428 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10619 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3796 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5945 | 0.020 |
Why?
|
Psychotherapy | 1 | 2015 | 1648 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9602 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4853 | 0.020 |
Why?
|
Acute Disease | 1 | 1996 | 7241 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3230 | 0.020 |
Why?
|
Autopsy | 1 | 2009 | 1011 | 0.020 |
Why?
|
Atherectomy | 1 | 2005 | 41 | 0.020 |
Why?
|
History, 20th Century | 1 | 2013 | 2764 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2020 | 4306 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2008 | 1587 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2020 | 18984 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3692 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3666 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20708 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9661 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5514 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 13050 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8307 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2971 | 0.010 |
Why?
|
Pregnancy | 2 | 2015 | 30237 | 0.010 |
Why?
|
Equipment Design | 1 | 2008 | 3487 | 0.010 |
Why?
|
Medical Records | 1 | 2005 | 1408 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3927 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1217 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4056 | 0.010 |
Why?
|
Treatment Failure | 1 | 2005 | 2659 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4858 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2015 | 4628 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5306 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11920 | 0.010 |
Why?
|
Stents | 1 | 2005 | 3193 | 0.010 |
Why?
|
Coronary Disease | 1 | 2005 | 5915 | 0.010 |
Why?
|
Internship and Residency | 1 | 2008 | 5943 | 0.000 |
Why?
|